Device Speaker Programs: Paid Education or Paid Referrals?

Medical device speaker program kickbacks use payments for supposed education to induce or reward a physician’s device recommendations, orders or use covered by federal health care programs. A presentation can take place while the commercial purpose sits elsewhere: in the choice of speaker, the audience invited back or the sales manager’s approval. If you work in sales, clinical training or program administration, you may know why that physician got the engagement and what the company expected in return.

The company’s money reaches people who influence its sales, sometimes through an event that looks like a professional obligation. The useful question is what the company was buying with that payment.

Why Is a Kickback Illegal?

A kickback puts the payer’s financial interest into a decision that should serve the patient. The Anti-Kickback Statute prohibits deliberately paying or accepting money or other benefits to induce or reward business covered by a federal health care program. In the device business, the decision may be which implant to use in an operation.

The physician can strongly influence the brand and type of implant while the hospital or surgery center buys it. Medicare usually pays for the procedure or hospital stay with the implant’s cost included. The manufacturer pays the speaker, the physician influences product use, and the institution submits the claim. That split explains why the speaker agreement and the bill to Medicare may sit in different businesses.

Patients depend on the physician’s judgment. Taxpayers pay for the resulting care. The evidence connects the payment’s purpose to the device decision and then to the claim for that care.

What Makes the Education Look Like a Referral Payment?

Speaker selection, actual teaching, attendance and compensation show what an educational label can conceal. In its November 2020 Special Fraud Alert on speaker programs, the Department of Health and Human Services’ Office of Inspector General identified sales influence, repeated audiences and payments tied to past or expected business among the characteristics that can indicate an improper arrangement.

The alert reported that drug and device companies paid nearly $2 billion for speaker-related services in 2017, 2018 and 2019 combined. Its concern went to the purpose of the events:

Speaker Selection That Starts With Sales

A volume-based nomination puts the physician’s business at the beginning of the engagement. The Inspector General specifically identifies sales or marketing influence over speaker selection and the use of expected revenue or return-on-investment analysis to choose participants. Those records can explain why a particular physician became an educator.

The nomination, sales forecast and approval correspondence belong together. A program manager may see an approved speaker agreement. The sales representative may know the implant volume behind the nomination. We examine that connection with insiders who understand how the company selected its speakers and who could approve the payment.

The Same Audience, the Same Material

Repeat attendance matters when the same people return for substantially the same topic. The Inspector General also identifies repeated programs without new medical or scientific information, attendees who have already spoken on the subject, and audiences made up of the speaker’s own practice staff, friends or family without a business reason to attend.

The agenda states what was supposed to be taught. The attendance history shows who kept returning to hear it. Comparing them brings the educational purpose into focus: what did this audience need from this particular session? An employees-only event calls for the same attention to whose employees attended and what they were there to learn.

Actual Work and the Money Attached to It

The Inspector General identifies programs with little substantive content, compensation above fair market value and fees that account for the speaker’s past or potential business. Actual teaching time, the subject covered and the payment calculation therefore belong beside the contract. The alert also flags payments for training future speakers.

Meals, alcohol, travel and venue expenses complete the picture. The Inspector General identifies expensive meals and settings poorly suited to education, including entertainment and sports venues. Those expenses show what the recipient received. The speaker selection and attendance files show why that recipient was there. A presentation and a payment can both be real while the selection records tell the more revealing story. The alert also identifies benefits to attendees as a possible inducement to send business, so the payment trail can extend beyond the person giving the talk.

What Are Some Examples of Kickbacks in Healthcare?

Device speaker cases show payments reaching physicians through their own practice meetings, a manufacturer-backed surgical society and training for the manufacturer’s employees. LivaNova, NuVasive and Biotronik each illustrate a different part of that arrangement.

LivaNova and the Speaker’s Own Staff

LivaNova USA, formerly Cyberonics, agreed to a $1.87 million settlement with the United States and Georgia in December 2018. The government alleged that it paid high-referring epilepsy physicians to speak at events attended primarily by those physicians and their own staff. A former employee brought the whistleblower case.

The device was the Vagus Nerve Stimulator Therapy System used to treat drug-resistant epilepsy. Its implanted pulse generator sends electrical pulses through a lead attached to the vagus nerve. The speaker allegations concern referrals for this epilepsy treatment.

The audience is the telling detail. The alleged payment went to a physician already referring patients for the device, for an event largely attended by that physician’s own practice. The educational explanation has to account for both the selection of the speaker and the people listening.

The original whistleblower complaint also alleged honoraria ranging from $250 to $2,000 for speaking events that never occurred.

NuVasive and the Society That Looked Independent

NuVasive agreed to a $13.5 million settlement in July 2015 over alleged off-label promotion of spine products and kickbacks. The government alleged that promotional speaker fees, honoraria and attendance expenses ran through the Society of Lateral Access Surgery. It alleged that NuVasive created, funded and operated the society despite its outward appearance of independence.

The former sales representative’s complaint described the commercial condition for attending company training:

According to the complaint, a sales representative could request company payment for the surgeon’s flights, meals, rental car and entertainment, including golf. The complaint also described paid proctor surgeons presenting surgical techniques at company-funded meals. It alleged that the training promoted off-label uses of CoRoent XL implants.

The interest in future product use was part of the alleged selection condition. For an insider, the sales request explains something the event’s educational title cannot: why the company was willing to pay for that surgeon to attend. The society’s funding and operating arrangements answer the corresponding question about the organizer.

A society name on an invitation can put distance between the physician and the sponsor in public, while the company’s own approval and payment records show who ran the event.

Biotronik’s Payments to Physicians for Training Its Own Staff

Biotronik agreed to a $12.95 million settlement in July 2022 over alleged kickbacks connected to Medicare and Medicaid claims for pacemakers and defibrillators. The government alleged excessive payments for employee training, including sessions that never happened or offered little or no value to trainees. Former independent sales representatives brought the whistleblower case.

The direction of the teaching matters. Physicians allegedly received money to train the manufacturer’s new employees. According to the government, Biotronik’s compliance department warned that salespeople had too much influence over physician selection and that the training payments were being overused.

The whistleblowers’ amended complaint makes the paperwork problem concrete. It alleged that staff signed forms claiming they attended training sessions when they had not. The physicians allegedly received approximately $400 per procedure despite performing no training at all.

One whistleblower also alleged that he kept being sent to observe implant procedures after he already had substantial experience selling and servicing cardiac devices. His account described continued payments to physicians for letting him stand behind them during surgery, with no extra work required of the physician. The training calendar and the employee’s experience become part of the same inquiry: what instruction was the company paying for?

The government also alleged business-class airfare and honoraria for brief appearances at international conferences.

The earlier Biotronik settlement in 2014 concerned alleged repeated expensive meals and inflated physician advisory-board payments intended to induce device use. Across the separate matters, the labels changed while the central commercial relationship remained the same: the manufacturer allegedly paid physicians who could choose its implants.

What Evidence Is Needed to Prove Fraud?

Evidence of speaker-program fraud connects why the physician was paid, what work occurred, the device decision and the resulting government claim. An insider may know the program file without seeing the hospital bill. We work with you to connect those parts of the case.

An agenda can promise training while attendance records and participants tell another story. The Biotronik allegations show why a signed form needs to be read beside what employees know happened.

Contracts and expenses show what the physician received. Speaker nominations and sales approvals can explain why that physician got the work. Compliance correspondence can show that the company kept paying after its own staff questioned the program.

Open Payments and the Company’s Own Explanation

Open Payments supplies the manufacturer’s public description of a transfer to a physician. Its payment category can be compared with the agreement, calendar, work product and operating schedule. The useful comparison is between what the company reported and the service the recipient actually performed.

Payment timing and implant-use records add the sales side. Venue and vendor records can identify where noncash benefits went. Together, these comparisons can expose a difference between the stated purpose and the company’s internal explanation for spending the money.

From the Physician’s Choice to the Hospital’s Claim

Hospital purchasing and procedure records connect the physician’s device choice to the care billed. In consignment arrangements, the manufacturer may retain ownership until the device is used. Implantation can therefore trigger the sale while also forming part of the hospital’s reimbursed procedure.

The hospital claim does not identify the implant by its unique device identifier. The payer can see a procedure without seeing which model went into the patient. The product and clinical records supply a connection the payment record alone cannot give.

Can a Whistleblower Take Legal Action Against a Medical Device Company?

Yes. A whistleblower can bring a False Claims Act case against a manufacturer over false claims it caused a hospital or physician to submit. The company paying the speaker can face a case even when another business sends the bill. In the device cases above, former employees and independent sales representatives supplied the inside knowledge.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. We work with you to connect what you saw inside the program to the payments, product decisions and claims that make the case specific.

You Know Why That Physician Was Chosen

If you know how sales selected the speakers, who actually attended or why training payments kept coming, talk with our whistleblower experts about the program behind those payments. We build your medical device whistleblower case around the decisions and records that connect the education budget to product use. We bring in medical device kickback whistleblower lawyers and stay beside you through the case.